XML 55 R40.htm IDEA: XBRL DOCUMENT v3.10.0.1
Summary of Significant Accounting Policies - Additional Information (Detail)
3 Months Ended 12 Months Ended
Dec. 31, 2018
USD ($)
Sep. 30, 2018
USD ($)
Jun. 30, 2018
USD ($)
Mar. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Sep. 30, 2017
USD ($)
Jun. 30, 2017
USD ($)
Mar. 31, 2017
USD ($)
Dec. 31, 2018
USD ($)
Distributor
Dec. 31, 2017
USD ($)
Distributor
Dec. 31, 2016
USD ($)
Jan. 01, 2018
USD ($)
Jul. 01, 2013
USD ($)
Summary Of Significant Accounting Policies [Line Items]                          
Net deferred revenue         $ 3,038,000         $ 3,038,000      
Revenue $ 16,031,000 $ 4,469,000 $ 3,893,000 $ 3,465,000 4,530,000 $ 2,043,000 $ 2,163,000 $ 3,009,000 $ 27,859,000 $ 11,745,000 $ 174,758,000    
Number of wholesale distributors | Distributor                 3 3      
Percentage of product shipments to wholesale distributors                 89.00% 89.00%      
Deferred costs from commercial product sales         405,000         $ 405,000      
Current deferred payment 36,885,000       250,000       $ 36,885,000 250,000      
Long-term deferred payment 10,680,000       500,000       $ 10,680,000 $ 500,000      
Maturity period of cash equivalents                 90 days or less at the time of purchase 90 days from the date of purchase      
Inventory charge                 $ 2,212,000 $ 2,971,000 0    
Prepaid expenses and other current assets 2,556,000       3,010,000       $ 2,556,000 3,010,000      
Long-lived assets anticipated sale in year                 1 year        
Asset impairment charge                   200,000 1,300,000    
Purchase commitment obligation 98,300,000       109,300,000       $ 98,300,000 109,300,000      
Liability for uncertainty in income taxes 0               0        
Interest cost capitalized                 0 0      
Increase of assets and liabilities arising from operating leases upon adoption of ASU 5,000               5,000        
Milestone Rights Liability | Deerfield                          
Summary Of Significant Accounting Policies [Line Items]                          
Contingent liability for milestone payments, remain payable amount 75,000,000               75,000,000        
Milestone Rights Liability | Deerfield | 2019 notes                          
Summary Of Significant Accounting Policies [Line Items]                          
Long term liability 8,900,000       8,900,000       8,900,000 8,900,000      
Certificates of Deposit                          
Summary Of Significant Accounting Policies [Line Items]                          
Prepaid expenses and other current assets 400,000       400,000       400,000 400,000      
Intellectual property                          
Summary Of Significant Accounting Policies [Line Items]                          
Revenue                   600,000      
Maximum | Milestone Rights Liability | Deerfield                          
Summary Of Significant Accounting Policies [Line Items]                          
Contingent liability for milestone payments 90,000,000               90,000,000       $ 90,000,000
Accounting Standards Update 2014-09                          
Summary Of Significant Accounting Policies [Line Items]                          
Deferred costs from commercial product sales                       $ 0  
AFREZZA product sales                          
Summary Of Significant Accounting Policies [Line Items]                          
Net deferred revenue         3,000,000         3,000,000      
Revenue                 $ 17,276,000 9,192,000 1,895,000    
AFREZZA product sales | Minimum                          
Summary Of Significant Accounting Policies [Line Items]                          
Sales return right following product expiration in months                 6 months        
AFREZZA product sales | Maximum                          
Summary Of Significant Accounting Policies [Line Items]                          
Sales return right following product expiration in months                 12 months        
AFREZZA product sales | Accounting Standards Update 2014-09                          
Summary Of Significant Accounting Policies [Line Items]                          
Net deferred revenue 0               $ 0        
Collaborations and services                          
Summary Of Significant Accounting Policies [Line Items]                          
Revenue                 10,583,000 250,000 $ 171,965,000    
Current deferred payment 36,900,000       200,000       36,900,000 200,000      
Long-term deferred payment $ 10,700,000       $ 500,000       $ 10,700,000 500,000      
Bulk insulin sales                          
Summary Of Significant Accounting Policies [Line Items]                          
Revenue                   $ 1,700,000